Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"

09:12 EST 26th November 2015 | BioPortfolio

Matching Channels

Freiberg Infraction

Freiberg's disease is an osteochondrosis of the metatarsal head, most commonly occurring in young athletes older than 12 years who perform on their toes in either sprinting or jumping activities...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to:    

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: 

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view:

G-protein-coupled receptors (GPCRs)

GPCRs are a large family of cell surface receptors that respond to a variety of external signals. Binding of a signaling molecule to a GPCR results in G protein activation, which in turn triggers th...

Matching News

Oxford provides up to $21mm in debt financing to ADMA Biologics

Oxford Finance provided infectious disease-focused ADMA Biologics Inc. with an initial $16mm loan to repay an existing loan. ADMA has the option to draw down another $5mm upon the approval of its BLA ...

ADMA Biologics seeks FDA approval for primary immunodeficiency treatment

A biologics license application has been filed with the FDA by ADMA Biologics for approval to market its RI-002 as a treatmen -More- 

BRIEF-Biotest continues cooperation with ADMA Biologics for RSV Hyperimmunoglobulin RI-002

* Continues cooperation with ADMA Biologics, Inc. for RSV Hyperimmunoglobulin RI-002

BRIEF-Capricor Therapeutics says positive data from trial evaluating CAP-1002

* Positive six-month safety and adverse event data from ongoing clinical trial evaluating CAP-1002

ADMA completes debt financing

FDA Accepts ADMA Biologics License Application for RI-002

RAMSEY, N.J., Sept. 21, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-...

ADMA Biologics Reports Third Quarter 2015 Results

RAMSEY, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasm...

ADMA Biologics Reports Second Quarter 2015 Results

RAMSEY, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-b...

Matching PubMed Articles

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.

Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia. Abnormal maternal sFLT1, PGF and ADMA...

Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles.

Multidrug resistance (MDR) presents a clinical obstacle to cancer chemotherapy. The main purpose of this study was to evaluate the potential of a hyaluronic acid (HA) and α-tocopheryl succinate (α-T...

Physical exercise reduces synthesis of ADMA, SDMA, and L-Arg.

Increased levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and low plasma level of L-arginine (L-ARG) are all conditions likely to decrease nitric oxide (NO) production....

Endothelial DDAH1 is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.

-Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthesis and a risk factor for cardiovascular disease. Dimethylarginine dimethylaminohydrolase (DDAH) enzymes are respon...

Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.

Hypoxia-induced and high altitude pulmonary hypertension are a major problem in the mountain areas of the world. The asymmetric methylarginines (ADMA) inhibit nitric oxide (NO) synthesis by competing ...

Search Whole site using Google


Advertisement Advertisement